Lamisil and Lymphocyte stimulation test positive - a phase IV clinical study of FDA data

Summary:

Lymphocyte stimulation test positive is reported as a side effect among people who take Lamisil (terbinafine hydrochloride), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Clarithromycin, and have Nail tinea.

The phase IV clinical study analyzes which people have Lymphocyte stimulation test positive when taking Lamisil. It is created by eHealthMe based on reports of 13,455 people who have side effects when taking Lamisil from the FDA, and is updated regularly.

What is Lamisil?

Lamisil has active ingredients of terbinafine hydrochloride. It is often used in pulmonary aspergilloma (mycetoma). eHealthMe is studying from 14,080 Lamisil users. Check the latest studies of Lamisil.

What is Lymphocyte stimulation test positive?

Lymphocyte stimulation test positive is found to be associated with 149 drugs and 450 conditions by eHealthMe. Check the latest studies of Lymphocyte stimulation test positive.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

13,455 people reported to have side effects when taking Lamisil.
Among them, 30 people (0.22%) have Lymphocyte stimulation test positive.

Could Lamisil cause Lymphocyte stimulation test positive?

Among these 30 people:

How long have people been on Lamisil when they have Lymphocyte stimulation test positive? *

What is the gender of people who have Lymphocyte stimulation test positive when taking Lamisil? *

female: 37.93 %
male: 62.07 %

What is the age of people who have Lymphocyte stimulation test positive when taking Lamisil? *

What are other drugs people take besides Lamisil? *

What are other side effects people have besides Lymphocyte stimulation test positive? *

White Blood Cell Count Increased: 13 people, 43.33%
Blood Alkaline Phosphatase Increased: 11 people, 36.67%
Alanine Aminotransferase Increased: 11 people, 36.67%
Aspartate Aminotransferase Increased: 11 people, 36.67%
Fever: 11 people, 36.67%
Liver Disorder (liver diseases): 11 people, 36.67%
Gamma-Glutamyltransferase Increased: 10 people, 33.33%
Blood Bilirubin Increased: 10 people, 33.33%
C-Reactive Protein Increased: 10 people, 33.33%
Acute Kidney Failure: 7 people, 23.33%

What are the existing conditions these people have? *

Nail Tinea (fungal infection of nail): 13 people, 43.33%
Seborrhoeic Dermatitis (a common, inflammatory skin condition that causes flaky, white to yellowish scales to form on oily areas such as the scalp): 6 people, 20.00%
Diabetes: 3 people, 10.00%
Body Tinea (ringworm of the body): 2 people, 6.67%
High Blood Pressure: 2 people, 6.67%
Type 1 Diabetes: 2 people, 6.67%
Bronchitis Chronic (inflammation of the mucous membrane in the bronchial tubes- chronic): 1 person, 3.33%
Cerebral Infarction (less blood supply to brain resulting tissue damage): 1 person, 3.33%
Diarrhea: 1 person, 3.33%
Gastric Ulcer (stomach ulcer): 1 person, 3.33%

* Approximation only. Some reports may have incomplete information.

Do you take Lamisil and have Lymphocyte stimulation test positive?

- Check whether Lymphocyte stimulation test positive is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lamisil:

Lamisil (14,080 reports)

Browse all side effects of Lamisil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Lymphocyte stimulation test positive:

Lymphocyte stimulation test positive (149 drugs)

Browse all the conditions that are associated with Lymphocyte stimulation test positive:

Lymphocyte stimulation test positive (450 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on terbinafine hydrochloride (the active ingredients of Lamisil) and Lamisil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.